van Bergen J, Götz H M, Richardus J H, Hoebe C J P A, Broer J, Coenen A J T
STI AIDS the Netherlands, Amsterdam, the Netherlands.
Sex Transm Infect. 2005 Feb;81(1):17-23. doi: 10.1136/sti.2004.010173.
Chlamydia trachomatis (Chlamydia) is the most prevalent sexually transmitted bacterial infection and can cause considerable reproductive morbidity in women. Chlamydia screening programmes have been considered but policy recommendations are hampered by the lack of population based data. This paper describes the prevalence of Chlamydia in 15-29 year old women and men in rural and urban areas, as determined through systematic population based screening organised by the Municipal Public Health Services (MHS), and discusses the implications of this screening strategy for routine implementation.
Stratified national probability survey according to "area address density" (AAD). 21 000 randomly selected women and men in four regions, aged 15-29 years received a home sampling kit. Urine samples were returned by mail and tested by polymerase chain reaction (PCR). Treatment was via the general practitioner, STI clinic, or MHS clinic.
41% (8383) responded by sending in urine and questionnaire. 11% (2227) returned a refusal card. Non-responders included both higher and lower risk categories. Chlamydia prevalence was significantly lower in rural areas (0.6%, 95% CI 0.1 to 1.1) compared with very highly urbanised areas (3.2%, 95% CI 2.4 to 4.0). Overall prevalence was 2.0% (95% CI 1.7 to 2.3): 2.5% (95% CI 2.0 to 3.0%) in women and 1.5% (95% CI 1.1 to 1.8) in men. Of all cases 91% were treated. Infection was associated with degree of urbanisation, ethnicity, number of sex partners, and symptoms.
This large, population based study found very low prevalence in rural populations, suggesting that nationwide systematic screening is not indicated in the Netherlands and that targeted approaches are a better option. Further analysis of risk profiles will contribute to determine how selective screening can be done.
沙眼衣原体(衣原体)是最常见的性传播细菌感染,可导致女性出现相当严重的生殖系统疾病。虽然已经考虑过衣原体筛查项目,但由于缺乏基于人群的数据,政策建议受到阻碍。本文描述了通过市公共卫生服务机构(MHS)组织的基于人群的系统筛查所确定的农村和城市地区15至29岁女性和男性中衣原体的患病率,并讨论了这种筛查策略对常规实施的影响。
根据“区域地址密度”(AAD)进行分层全国概率调查。在四个地区随机选择了21000名年龄在15至29岁之间的女性和男性,他们收到了家庭采样试剂盒。尿液样本通过邮寄返回,并通过聚合酶链反应(PCR)进行检测。治疗通过全科医生、性传播感染诊所或MHS诊所进行。
41%(8383人)通过邮寄尿液和问卷进行了回应。11%(2227人)返回了拒绝卡。未回应者包括高风险和低风险类别。与高度城市化地区(3.2%,95%可信区间2.4至4.0)相比,农村地区的衣原体患病率显著较低(0.6%,95%可信区间0.1至1.1)。总体患病率为2.0%(95%可信区间):女性为2.5%(95%可信区间2.0至3.0%),男性为1.5%(95%可信区间1.1至1.8)。所有病例中有91%接受了治疗。感染与城市化程度、种族、性伴侣数量和症状有关。
这项基于人群的大型研究发现农村人群中的患病率非常低,这表明在荷兰全国范围内进行系统筛查并不合适,有针对性的方法是更好的选择。对风险概况的进一步分析将有助于确定如何进行选择性筛查。